Hikma Pharmaceutical | HIK - Gross Profit On Sales

Stock Price
1,540.00
Daily Change
-12.00 -0.77%
Monthly
-1.72%
Yearly
-32.57%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $362.5M in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
argenx SE USD 1.02B 180.32M Sep/2025
AstraZeneca USD 12.39B 406M Sep/2025
Autolus Therapeutics Ltd USD -7.45M 3.93M Sep/2025
Bayer EUR 5.35B 1.02B Sep/2025
Fresenius EUR 1.3B 158M Sep/2025
Galapagos EUR -13.57M 74.82M Sep/2025
Genmab DKK 868M 195M Jun/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.21B 186M Sep/2025
Orion EUR 254.2M 5.9M Sep/2025
Recordati EUR 423.85M 34.92M Jun/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
UCB EUR 2.46B 520M Dec/2024